CHICAGO--(BUSINESS WIRE)--CytoCore Inc. (OTCBB:CYOE), the biopharmaceutical research and medical device company for early detection and treatment of reproductive-tract cancers, announced today its first delivery of SoftPAP™ cell collectors in Europe.